World's Best Scientists 2026 revealed!
Erkka Valovirta

Erkka Valovirta

D-Index & Metrics

Immunology

D-Index
76
Citations
40531
World Ranking
1861
National Ranking
12

Medicine

D-Index
76
Citations
40547
World Ranking
18602
National Ranking
210

Erkka Valovirta publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Erkka Valovirta sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 196 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Erkka Valovirta D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Erkka Valovirta sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Erkka Valovirta is affiliated with the University of Turku in Finland, focusing on medical research with a specialization in immunology and allergy. Their scholarly contributions span 36 publications in the broader field of medicine, including subfields such as immunology and allergy, physiology, health toxicology and mutagenesis, dermatology, and pulmonary and respiratory medicine.

The research topics addressed by Erkka Valovirta primarily include allergic rhinitis and sensitization, asthma and respiratory diseases, dermatology and skin diseases, food allergy and anaphylaxis research, air quality and health impacts, respiratory and cough-related research, and climate change and health impacts.

Valovirta's recent papers emphasize allergic and respiratory conditions, reflecting collaborative efforts with various researchers. Notable recent publications include:

  • "Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis" (2023, Allergy)
  • "Allergic Rhinitis in Childhood and the New EUFOREA Algorithm" (2021, Frontiers in Allergy)
  • "Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus" (2021, Allergy)
  • "The Finnish Allergy Program 2008-2018: Society-wide proactive program for change of management to mitigate allergy burden" (2021, Journal of Allergy and Clinical Immunology)
  • "Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®" (2021, Clinical and Translational Allergy)

Collaborative relationships form a significant part of Valovirta's academic profile. Frequent coauthors include:

  • Jean Bousquet
  • Tari Haahtela
  • Nikolaos G. Papadopoulos
  • Ludger Klimek
  • Violeta Kvedarienė

Valovirta publishes predominantly in the following academic journals:

  • Allergy
  • Clinical and Translational Allergy
  • The Journal of Allergy and Clinical Immunology In Practice
  • Frontiers in Allergy
  • Journal of Allergy and Clinical Immunology

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

    J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

  • Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

    Jan L. Brożek;Jean Bousquet;Ioana Agache;Arnav Agarwal

  • Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

    Christian Möller;Sten Dreborg;Hosne Ara Ferdousi;Susanne Halken

  • Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

    L. Jacobsen;B. Niggemann;S. Dreborg;Hosne Ara Ferdousi

  • Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report

    L. B. Bacharier;A. Boner;K.-H. Carlsen;P. A. Eigenmann

  • International consensus on (ICON) pediatric asthma

    N. G. Papadopoulos;H. Arakawa;A. Custovic;J. Gern

  • Standards for practical allergen-specific immunotherapy

    E. Alvarez-Cuesta;J. Bousquet;G. W. Canonica;S. R. Durham

  • Sub-Lingual Immunotherapy: World Allergy Organization Position Paper 2009

    G Walter Canonica;Jean Bousquet;Thomas Casale;Richard F Lockey

  • Allergen immunotherapy: therapeutic vaccines for allergic diseases

    J. Bousquet;R. Lockey;H.J. Malling;E. Alvarez-Cuesta

  • Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

    Canonica Gw;Bousquet J;Casale T;Lockey Rf

  • Sublingual immunotherapy: World Allergy Organization position paper 2013 update

    Giorgio Walter Canonica;Linda Cox;Ruby Pawankar;Carlos E Baena-Cagnani

  • Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

    G. W. Canonica;C. E. Baena-Cagnani;J. Bousquet;P. J. Bousquet

  • Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

    Jean Bousquet;Holger J. Schünemann;Akdis Togias;Claus Bachert

  • Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: An EAACI Position Paper

    O. Pfaar;P. Demoly;R. Gerth van Wijk;S. Bonini

  • Five‐year follow‐up on the PAT study: specific immunotherapy and long‐term prevention of asthma in children

    B Niggemann;L Jacobsen;S Dreborg;H A Ferdousi

  • Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland.

    J. Bousquet;P. Van Cauwenberge;N. Khaltaev

  • Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy.

    Erkka Valovirta;Thomas H Petersen;Teresa Piotrowska;Mette K Laursen

  • Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology

    Graham Roberts;M. Xatzipsalti;L.M. Borrego;Adnan Custovic

  • Birch pollen allergy in Europe

    T. Biedermann;L. Winther;S. J. Till;P. Panzner

  • Clinical contraindications to allergen immunotherapy: an EAACI position paper.

    C Pitsios;P Demoly;M B Bilò;R Gerth van Wijk

Frequent Co-Authors

Jean Bousquet
Jean Bousquet University of Montpellier
Pascal Demoly
Pascal Demoly University of Montpellier
Tari Haahtela
Tari Haahtela University of Helsinki
Claus Bachert
Claus Bachert Karolinska Institute
Nikolaos G. Papadopoulos
Nikolaos G. Papadopoulos National and Kapodistrian University of Athens
Piotr Kuna
Piotr Kuna Medical University of Lodz
João Fonseca
João Fonseca University of Porto
Magnus Wickman
Magnus Wickman Karolinska Institute
Torsten Zuberbier
Torsten Zuberbier Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring adjacent fields such as nursing can offer diverse career options. Many professionals choose to advance their education through programs like the cheap psych np programs, which provide cost-effective routes to becoming psychiatric nurse practitioners while broadening their expertise in immune and mental health connections.

Understanding salary expectations is also crucial. The dnp salary by specialty resource offers valuable insights into earning potential across different states and specialties, helping graduates make informed decisions about their career paths in health-related sectors.

For nurses seeking to specialize further, transitioning from roles such as family nurse practitioner to more acute care settings is possible. Guidance found in the fnp to acute care np pathway can assist professionals in navigating this transition smoothly.

Accelerated options also exist for those eager to fast-track their careers. The accelerated nurse practitioner program enables motivated students to complete their education efficiently while gaining the credentials needed to thrive in clinical and research roles intertwined with Immunology.

Best Scientists Citing Erkka Valovirta

Trending Scientists

Recently Published Articles